Gulf Medical Projects Company (PJSC) (ADX:GMPC)
United Arab Emirates · Delayed Price · Currency is AED 2.300
-0.040 (-1.71%)
At close: Aug 13, 2026
ADX:GMPC Income Statement
Financials in millions AED. Fiscal year is January - December.
Millions AED. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 781.86 | 767.52 | 677.34 | 569.64 | 503.83 | 486.83 | |
Revenue Growth | 13.26% | 13.31% | 18.91% | 13.06% | 3.49% | -0.09% |
Cost of Revenue | 571.48 | 557.23 | 490.71 | 425.95 | 386.47 | 358.76 |
Gross Profit | 210.38 | 210.29 | 186.63 | 143.69 | 117.37 | 128.07 |
Selling, General & Admin | 103.19 | 98.78 | 83.53 | 73.77 | 66.98 | 61.79 |
Amortization of Goodwill & Intangibles | 0 | 0 | 0 | 0 | 0 | 0 |
Other Operating Expenses | - | - | - | - | - | 4.29 |
Operating Expenses | 134.51 | 133.89 | 114.36 | 96.62 | 95.32 | 98.71 |
Operating Income | 75.86 | 76.4 | 72.27 | 47.07 | 22.05 | 29.36 |
Interest Expense | -0.12 | -0.14 | -0.15 | -0.2 | -0.23 | -0.85 |
Interest & Investment Income | 27.87 | 27.87 | 19.37 | 14 | 12.77 | 7.13 |
Other Non Operating Income (Expenses) | 14.06 | 15.8 | 7.8 | 5.56 | 4.7 | 5.07 |
EBT Excluding Unusual Items | 117.66 | 119.93 | 99.29 | 66.43 | 39.3 | 40.72 |
Gain (Loss) on Sale of Investments | 23.91 | 24.09 | -2.84 | 2.66 | 4.01 | 6.59 |
Gain (Loss) on Sale of Assets | 0.42 | 0.42 | -0.39 | 0.15 | 0.29 | 0.03 |
Asset Writedown | 2.11 | 2.11 | 13.09 | 5.99 | -0.07 | -3.33 |
Pretax Income | 144.11 | 146.56 | 109.15 | 75.23 | 43.52 | 44.01 |
Income Tax Expense | 11.16 | 11.39 | 9.1 | - | - | - |
Earnings From Continuing Operations | 132.95 | 135.17 | 100.05 | 75.23 | 43.52 | 44.01 |
Net Income to Company | 132.95 | 135.17 | 100.05 | 75.23 | 43.52 | 44.01 |
Minority Interest in Earnings | -26.06 | -26.66 | -22.16 | -15.42 | -6.92 | -8.43 |
Net Income | 106.89 | 108.51 | 77.89 | 59.81 | 36.6 | 35.58 |
Net Income to Common | 106.89 | 108.51 | 77.89 | 59.81 | 36.6 | 35.58 |
Net Income Growth | 27.97% | 39.31% | 30.23% | 63.40% | 2.87% | 2.97% |
Shares Outstanding (Basic) | 699 | 699 | 699 | 699 | 699 | 699 |
Shares Outstanding (Diluted) | 699 | 699 | 699 | 699 | 699 | 699 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | 0.15 | 0.16 | 0.11 | 0.09 | 0.05 | 0.05 |
EPS (Diluted) | 0.15 | 0.16 | 0.11 | 0.09 | 0.05 | 0.05 |
EPS Growth | 27.97% | 39.31% | 30.23% | 63.40% | 2.87% | 2.98% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 94.04 | 113.33 | 66.27 | 73.29 | 63.81 | 124.39 |
Free Cash Flow Per Share | 0.14 | 0.16 | 0.10 | 0.10 | 0.09 | 0.18 |
Dividend Per Share | 0.170 | 0.170 | 0.150 | 0.100 | 0.100 | 0.100 |
Dividend Growth | 13.33% | 13.33% | 50.00% | 0% | 0% | 0% |
Gross Margin | 26.91% | 27.40% | 27.55% | 25.22% | 23.29% | 26.31% |
Operating Margin | 9.70% | 9.95% | 10.67% | 8.26% | 4.38% | 6.03% |
Profit Margin | 13.67% | 14.14% | 11.50% | 10.50% | 7.27% | 7.31% |
Free Cash Flow Margin | 12.03% | 14.77% | 9.78% | 12.87% | 12.67% | 25.55% |
EBITDA | 103.4 | 103.77 | 97.95 | 71.55 | 46.33 | 54.04 |
EBITDA Margin | 13.22% | 13.52% | 14.46% | 12.56% | 9.20% | 11.10% |
D&A For EBITDA | 27.53 | 27.37 | 25.68 | 24.48 | 24.28 | 24.68 |
EBIT | 75.86 | 76.4 | 72.27 | 47.07 | 22.05 | 29.36 |
EBIT Margin | 9.70% | 9.95% | 10.67% | 8.26% | 4.38% | 6.03% |
Effective Tax Rate | 7.74% | 7.77% | 8.34% | - | - | - |
Advertising Expenses | - | 5.58 | 4.91 | 2.23 | 1.81 | 4.86 |